Skip to content
The Chat Archive
gpt-4.1-mini-2025-04-14· OpenAI WildChat-4.8M (AI2)

A nurse is caring for a client who is postpartum and breastfeeding. The client asks the…

  1. User

    A nurse is caring for a client who is postpartum and breastfeeding. The client asks the nurse about the effects that taking over-the-counter medications will have on her newborn. Which of the following should the nurse consider when recommending a medication for the client? (Select all that apply.)

    The newborn's weight

    How much breast milk the newborn consumes each day

    Whether or not the benefits to the client outweigh the risks to the newborn

    The properties of the medication

    The route of adm

  2. Assistant

    When a nurse is advising a postpartum breastfeeding client about over-the-counter (OTC) medications, several factors must be considered to ensure the safety of both the mother and the newborn. The following are important considerations:

    • Whether or not the benefits to the client outweigh the risks to the newborn: It's essential to balance the therapeutic benefits for the mother against the potential risk of medication exposure to the infant through breast milk.

    • The properties of the medication: The medication's molecular weight, half-life, solubility, protein binding, and ability to concentrate in breast milk affect how much of the drug passes to the infant.

    • The newborn's weight: The infant's size can influence their vulnerability to medication effects; smaller or premature infants may be more sensitive or have immature metabolism to process medications.

    • How much breast milk the newborn consumes each day: The volume of milk ingested affects the amount of medication exposure for the infant.

    • The route of administration: This affects maternal blood levels and therefore the amount of drug passed into breast milk. For example, topical or local medications may result in minimal systemic absorption and low exposure to the infant.


    Therefore, all of the options should be considered when recommending an OTC medication for a breastfeeding client:

    • The newborn's weight
    • How much breast milk the newborn consumes each day
    • Whether or not the benefits to the client outweigh the risks to the newborn
    • The properties of the medication
    • The route of administration
  3. User

    A client is about to start taking sustained-release glipizide to treat type 2 diabetes mellitus. Which of the following instructions should the nurse include when talking with the client about taking this medication? A Chew the tablet completely before swallowing it. B Take it once a day, 30 min before breakfast. C Take it in the evening before bedtime. D Drink 16 oz of water right after taking it.

  4. Assistant

    The correct instruction for taking sustained-release (SR) glipizide is:

    B. Take it once a day, 30 min before breakfast.


    Explanation:

    • Glipizide is a sulfonylurea used to stimulate insulin secretion for managing type 2 diabetes mellitus.
    • The sustained-release (SR) form is designed for once-daily dosing.
    • It should be taken about 30 minutes before a meal (usually breakfast) to maximize absorption and effectiveness.
    • Option A: Do not chew the sustained-release tablet. It should be swallowed whole to maintain the extended-release properties.
    • Option C: Taking it at bedtime is not recommended because it increases the risk for hypoglycemia during sleep.
    • Option D: There is no requirement to drink 16 oz of water with the medication; normal fluid intake is fine.

    Summary:

    Tell the client to take sustained-release glipizide once daily, about 30 minutes before breakfast, and to swallow the tablet whole.

  5. User

    The nurse is caring for a client who takes acarbose and sulfonylurea to treat type 2 diabetes mellitus. Which of the following is an indication of an adverse reaction to this medication combination? A Polyuria B Tremors C Bradycardia D Thirst

  6. Assistant

    The correct answer is:

    B. Tremors


    Explanation:

    • Acarbose is an alpha-glucosidase inhibitor that slows carbohydrate absorption, helping control postprandial blood glucose.
    • Sulfonylureas stimulate insulin secretion and can cause hypoglycemia as an adverse effect.
    • When acarbose is combined with sulfonylureas, the risk of hypoglycemia increases.

    Signs of hypoglycemia include:

    • Tremors or shakiness
    • Sweating
    • Palpitations
    • Anxiety or nervousness
    • Hunger
    • Confusion or dizziness

    Tremors are a classic sign of hypoglycemia.


    The other options:

    • A. Polyuria (frequent urination) and D. Thirst are signs of hyperglycemia or poorly controlled diabetes.
    • C. Bradycardia is not typically related to these medications or hypoglycemia.

    Therefore, tremors indicate an adverse reaction (hypoglycemia) in a client taking acarbose and sulfonylurea together.